ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

No reported Revenue figures are available to summarize.

Revenue history

Currency unavailable · from the income statement

No Revenue data reported for this period type.

Revenue vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Revenue for ADRX and competitors
Company Period LTM YoY 3-year CAGR
MGTXMeiraGTx Holdings plcLTM Mar 2026$79.76M USD+131.1%+72.3%
WVEWave Life Sciences Ltd.LTM Mar 2026$71.8M USD-31.6%+127.1%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$45.35M USD-66.4%-31.1%
STOKStoke Therapeutics, Inc.LTM Mar 2026$32.08M USD-83.2%+145.9%
RNAAtrium Therapeutics, Inc.FY2025$18.62M USD——
PRQRProQR Therapeutics N.V.LTM Mar 2026€13.44M EUR-29.2%+62.0%
PRMEPrime Medicine, Inc.LTM Mar 2026$4.03M USD+4.9%—
SLNSilence Therapeutics plcLTM Mar 2026$921.49K USD—-68.4%
BNTCBenitec Biopharma Inc.LTM Mar 2026$0 USD——
ADRXADARx Pharmaceuticals, Inc.—— ——
Peer median (excluding ADRX) —-30.4%+67.1%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.